21/12/2021
9:05 AM
|
|
ArtemiC Long COVID Syndrome Clinical Study Commenced
5
pages
1.1MB
|
16/12/2021
3:06 PM
|
|
Notification regarding unquoted securities - MXC
5
pages
26.5KB
|
08/12/2021
1:30 PM
|
|
s708A(5)(e) Cleansing Notice
2
pages
999.1KB
|
08/12/2021
1:23 PM
|
|
Application for quotation of securities - MXC
6
pages
27.8KB
|
08/12/2021
1:23 PM
|
|
Application for quotation of securities - MXC
6
pages
27.9KB
|
01/12/2021
3:09 PM
|
|
s708A(5)(e) Cleansing Notice
2
pages
1.0MB
|
01/12/2021
12:07 PM
|
|
Proposed issue of securities - MXC
6
pages
31.4KB
|
01/12/2021
12:07 PM
|
|
UK Capital Raising Completed
4
pages
267.9KB
|
30/11/2021
9:21 AM
|
|
Trading Halt
2
pages
1.2MB
|
25/11/2021
9:25 AM
|
|
Production Completed of A$1M ArtemiC Order from SPC
2
pages
877.6KB
|
25/11/2021
8:16 AM
|
|
Results of 2021 Annual General Meeting
2
pages
210.5KB
|
24/11/2021
2:15 PM
|
|
Issue of Shares and Convertible Note Maturity Extension
2
pages
866.0KB
|
24/11/2021
2:04 PM
|
|
Proposed issue of securities - MXC
5
pages
27.4KB
|
24/11/2021
1:39 PM
|
|
Appendix 3Y - Change of Director's Interest Notice
2
pages
586.2KB
|
24/11/2021
1:35 PM
|
|
Application for quotation of securities - MXC
8
pages
32.7KB
|
24/11/2021
1:30 PM
|
|
Application for quotation of securities - MXC
6
pages
28.1KB
|
23/11/2021
9:31 AM
|
|
US Supply and Distribution Agreement Update
3
pages
953.8KB
|
19/11/2021
5:36 PM
|
|
AGM Webcast Registration Details
2
pages
799.8KB
|
17/11/2021
8:19 AM
|
|
Notice of upcoming release of shares from voluntary escrow
1
page
779.9KB
|
12/11/2021
5:30 PM
|
|
Section 323DB Jobkeeper Receipts Notice
2
pages
816.1KB
|
12/11/2021
5:21 PM
|
|
Notification regarding unquoted securities - MXC
7
pages
30.9KB
|
03/11/2021
8:14 AM
|
|
MALTA CIMETRA PRODUCTION FACILITY UPDATE
2
pages
253.4KB
|
02/11/2021
9:22 AM
|
|
CIMETRA DOSE FINDING STUDY APPROVAL
4
pages
294.4KB
|
26/10/2021
2:20 PM
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
10
pages
2.0MB
|
25/10/2021
5:53 PM
|
|
Annual Report to shareholders
76
pages
1.4MB
|
25/10/2021
5:00 PM
|
|
Letter to Shareholders - Dispatch of 2021 AGM Documents
3
pages
217.8KB
|
25/10/2021
4:53 PM
|
|
Notice of Annual General Meeting/Proxy Form
23
pages
1.2MB
|
15/10/2021
2:55 PM
|
|
Response to ASX Query Letter
5
pages
730.8KB
|
12/10/2021
9:11 AM
|
|
Investor Presentation - CimetrA
15
pages
1.7MB
|
07/10/2021
7:13 PM
|
|
Correction to Announcement Title - Issue of Shares
1
page
779.2KB
|
07/10/2021
5:25 PM
|
|
s708A(5)(e) Cleansing Notice
2
pages
988.9KB
|
07/10/2021
4:15 PM
|
|
Appendix 3Y
2
pages
586.8KB
|
07/10/2021
4:10 PM
|
|
Issue of shares and resignation of Company Secretary
2
pages
988.9KB
|
07/10/2021
4:01 PM
|
|
Application for quotation of securities - MXC
6
pages
28.6KB
|
07/10/2021
9:30 AM
|
|
AMC INC. PLACES US$3M CIMETRA PURCHASE ORDER
4
pages
976.8KB
|
06/10/2021
8:25 AM
|
|
Company Presentation
23
pages
3.1MB
|
04/10/2021
3:18 PM
|
|
Change of Director's Interest Notice - Appendix 3Y
2
pages
204.7KB
|
30/09/2021
4:19 PM
|
|
Appendix 4G and Corporate Governance Statement
25
pages
1.4MB
|
30/09/2021
4:13 PM
|
|
Full Year Statutory Accounts
71
pages
1.8MB
|
30/09/2021
8:10 AM
|
|
FIRST ORDER RECEIVED UNDER US SUPPLY AGREEMENT
2
pages
237.3KB
|
22/09/2021
3:47 PM
|
|
s708A(5)(e) Cleansing Notice
2
pages
239.1KB
|
22/09/2021
3:44 PM
|
|
Application for quotation of securities - MXC
6
pages
28.0KB
|
20/09/2021
4:29 PM
|
|
s708A(5)(e) Cleansing Notice
2
pages
988.7KB
|
20/09/2021
4:18 PM
|
|
Application for quotation of securities - MXC
6
pages
28.0KB
|
20/09/2021
4:12 PM
|
|
Application for quotation of securities - MXC
6
pages
28.0KB
|
16/09/2021
9:38 AM
|
|
ARTEMIC EU SALE APPROVAL AND CLINICAL TRIAL UPDATE
6
pages
319.7KB
|
14/09/2021
8:16 AM
|
|
UK IMPORT PERMIT GRANTED FOR CANNEPIL
4
pages
1.1MB
|
10/09/2021
6:31 PM
|
|
Update - Notification of cessation of securities - MXC
4
pages
24.1KB
|
10/09/2021
6:11 PM
|
|
Update - Application for quotation of securities - MXC
8
pages
33.3KB
|
09/09/2021
6:39 PM
|
|
s708(5)(e) Cleansing Notice
2
pages
239.9KB
|
09/09/2021
6:26 PM
|
|
Appendix 3Y x 6
13
pages
334.2KB
|
09/09/2021
6:23 PM
|
|
Notification regarding unquoted securities - MXC
9
pages
38.5KB
|
09/09/2021
6:23 PM
|
|
Notification of cessation of securities - MXC
4
pages
24.5KB
|
09/09/2021
6:22 PM
|
|
Application for quotation of securities - MXC
8
pages
33.7KB
|
03/09/2021
9:43 AM
|
|
CIMETRA IMPORT APPROVAL GRANTED FOR INDIA
3
pages
269.5KB
|
01/09/2021
8:14 AM
|
|
Preliminary Final Report
15
pages
572.5KB
|
30/08/2021
5:43 PM
|
|
Proposed issue of securities - MXC
5
pages
28.1KB
|
27/08/2021
5:03 PM
|
|
Information on expiring options
2
pages
181.5KB
|
27/08/2021
8:04 AM
|
|
MGC PHARMA EXECUTES US$24M US SUPPLY AGREEMENT
5
pages
346.1KB
|
13/08/2021
8:20 AM
|
|
Results of General Meeting
2
pages
285.9KB
|
06/08/2021
5:26 PM
|
|
General Meeting Web Cast Facility
1
page
199.9KB
|
03/08/2021
8:21 AM
|
|
Notice to Holders of Expiring Options
4
pages
1.5MB
|
27/07/2021
8:22 AM
|
|
Quarterly Activities/Appendix 4C Cash Flow Report
12
pages
1.2MB
|
20/07/2021
5:03 PM
|
|
Response to ASX Query Letter
6
pages
716.4KB
|
16/07/2021
4:30 PM
|
|
Amendment to Appendix 3H lodged 13 July 2021
6
pages
431.6KB
|
15/07/2021
7:22 PM
|
|
PATENT APPLICATION LODGED FOR NOVEL DRUG DELIVERY SYSTEM
3
pages
277.2KB
|
13/07/2021
6:56 PM
|
|
Notification of cessation of securities - MXC
4
pages
24.4KB
|
13/07/2021
4:28 PM
|
|
s708A(5)(e) Cleansing Notice - Issue of Shares
2
pages
240.9KB
|
13/07/2021
4:27 PM
|
|
Application for quotation of securities - MXC
7
pages
30.9KB
|
13/07/2021
9:29 AM
|
|
1ST PATIENT RECRUITED INTO CIMETRA PHASE 3 CLINICAL TRIAL
4
pages
968.1KB
|
09/07/2021
1:01 PM
|
|
Cleansing Notice on Issue of Shares
2
pages
241.1KB
|
09/07/2021
12:45 PM
|
|
Application for quotation of securities - MXC
6
pages
27.7KB
|
09/07/2021
11:28 AM
|
|
Notice of General Meeting/Proxy Form
37
pages
2.1MB
|
15/06/2021
9:38 AM
|
|
CANNEPIL AVAILABLE FOR FREE DISPENSING IN IRELAND
3
pages
275.3KB
|
15/06/2021
8:23 AM
|
|
Issue of shares and resignation of Company Secretary
2
pages
243.1KB
|
15/06/2021
8:22 AM
|
|
Application for quotation of securities - MXC
6
pages
27.8KB
|
15/06/2021
8:21 AM
|
|
Application for quotation of securities - MXC
6
pages
27.8KB
|
11/06/2021
7:00 PM
|
|
Proposed issue of securities - MXC
5
pages
27.4KB
|
09/06/2021
4:12 PM
|
|
Company Secretary Appointment
1
page
238.3KB
|
25/05/2021
9:20 AM
|
|
MGC PHARMA 2021 CLINICAL TRIALS PROGRAM UPDATE
3
pages
214.7KB
|
18/05/2021
9:27 AM
|
|
CIMETRA PATENT SUBMITTED TO EUROPEAN IP OFFICE
2
pages
227.9KB
|
14/05/2021
4:14 PM
|
|
Appendix 3G x 3
36
pages
483.2KB
|
14/05/2021
4:06 PM
|
|
Appendix 2A
17
pages
516.8KB
|
07/05/2021
4:12 PM
|
|
FURTHER FINDINGS ON ARTEMIC AS ANTI-INFLAMMATORY AGENT
5
pages
380.9KB
|
06/05/2021
11:28 AM
|
|
Trading Halt
2
pages
204.0KB
|
06/05/2021
9:57 AM
|
|
Pause in Trading
1
page
112.3KB
|
04/05/2021
8:55 AM
|
|
$1M ORDER FOR ARTEMIC RESCUE FROM SWISS PHARMACAN
2
pages
207.6KB
|
28/04/2021
12:41 PM
|
|
ARTEMIC SUBMITTED TO HEALTH CANADA
2
pages
185.2KB
|
27/04/2021
8:22 AM
|
|
MARCH QUARTERLY ACTIVITY AND CASHFLOW REPORT
11
pages
814.7KB
|
22/04/2021
5:55 PM
|
|
Proposed issue of Securities - MXC
8
pages
34.4KB
|
22/04/2021
9:04 AM
|
|
MGC PHARMA TO ACQUIRE MEDICAL RESEARCH COMPANY MEDICANL
4
pages
240.8KB
|
16/04/2021
4:55 PM
|
|
Appendix 2A - Option Conversion
17
pages
513.5KB
|
09/04/2021
10:12 AM
|
|
INVESTOR PRESENTATION
25
pages
5.2MB
|
09/04/2021
8:22 AM
|
|
Proposed issue of Securities - MXC
7
pages
34.4KB
|
09/04/2021
8:21 AM
|
|
Change of Company Secretary, Perf Rights & Remuneration
2
pages
201.4KB
|
07/04/2021
9:34 AM
|
|
MXC COMPLETES FIRST ARTEMIC ORDER, MARCH QTR RECORD REVENUE
3
pages
355.2KB
|
01/04/2021
8:21 AM
|
|
Results of General Meeting
2
pages
352.3KB
|
24/03/2021
7:10 PM
|
|
Appendix 2A
16
pages
426.4KB
|
23/03/2021
9:03 AM
|
|
Ethics Committee Approval Granted Phase III Clinical Trial
6
pages
320.0KB
|
19/03/2021
4:19 PM
|
|
MGC Pharma General Meeting Information and Webinar
1
page
174.0KB
|
09/03/2021
7:03 PM
|
|
Appendix 2A
16
pages
427.8KB
|
09/03/2021
10:27 AM
|
|
Change of Director's Interest x3
8
pages
202.3KB
|
03/03/2021
9:31 AM
|
|
SwissPharmaCan AG increases initial purchase order
3
pages
285.6KB
|
26/02/2021
1:31 PM
|
|
Half Yearly Report and Accounts
26
pages
1.0MB
|
25/02/2021
7:22 PM
|
|
Notice of Meeting and Incentive Share Plan
27
pages
743.0KB
|
18/02/2021
10:25 AM
|
|
Master Suppy and Distribution Agreement for ArtemiC Rescue
4
pages
266.0KB
|
16/02/2021
7:09 PM
|
|
LSE Dual Listing & Depositary Interest Information
3
pages
223.2KB
|
15/02/2021
9:15 AM
|
|
New In-vitro cannabinoid study on Glioblastoma treatment
3
pages
272.4KB
|
11/02/2021
7:55 PM
|
|
Corporate Governance Plan
65
pages
656.1KB
|
10/02/2021
4:59 PM
|
|
Appendix 2A
16
pages
416.2KB
|
10/02/2021
8:17 AM
|
|
MGC Pharma Welcomes Admission to the LSE
2
pages
216.3KB
|
09/02/2021
5:32 PM
|
|
Proposed issue of Securities - MXC
5
pages
27.5KB
|
09/02/2021
4:43 PM
|
|
Disclosure Document
35
pages
311.3KB
|
04/02/2021
9:21 AM
|
|
Proposed issue of Securities - MXC
5
pages
28.3KB
|
04/02/2021
9:20 AM
|
|
MGC Pharma first medicinal cannabis company to list on LSE
3
pages
244.5KB
|
02/02/2021
9:15 AM
|
|
Trading Halt
2
pages
572.0KB
|
02/02/2021
8:22 AM
|
|
MGC Pharma Investor Presentation
27
pages
1.8MB
|
02/02/2021
8:21 AM
|
|
MGC Pharma to list on the London Stock Exchange
3
pages
227.8KB
|
22/01/2021
2:45 PM
|
|
December Quarterly Activity and Cashflow Report
10
pages
418.0KB
|
13/01/2021
11:38 AM
|
|
Key Appointment - Global Chief Sales Officer
2
pages
214.8KB
|